Suppression Studies in Affective Disorders *

Addison T. : “On the constitutional and local effects of disease of the suprarenal capsules.” In: A Collection of the Published Writings of Thomas Addison, London. New Sydenham Society, 36: 1868.

Armstrong C. W. J. , Austen D. C. , and Cleghorn R. A. : Blood pressure studies in adrenalized dogs. Amer. J. Physiol. 123: 40, 1938.

Barnard R. D. , and Fox H. L. : The affect of cholase administration in some dermatologic conditions. N.Y. State J. Med. 53: 2826–2830, 1953.

Bliss E. L. , Sandberg A. A. , Nelson D. H. ,., and Eik-Nes K. : The normal levels of 17-hydroxycorticosteroids in the peripheral blood of man. J. Clin. Invest. 32: 818, 1953.

Bliss E. L. , Migeon C. J. , Branch C. H. H. , and Samuels L. T. : Reaction of adrenal cortex to emotional stress. Psychosom. Med. 18: 56–76, 1956.

Board F. , Persky H. , and Hamburg D. A. : Psychological stress and endocrine function. Psychosom. Med. 18: 324–333, 1956.

Board F. , Wadeson R. , and Persky H. : Depressive affect and endocrine functions. AMA Neurol. Psychiat. 78: 612–620, 1957.

Bunney W. E. Jr. , Mason J. W. , and Hamburg D. A. : Correlations between behavioural variables and urinary 17-hydroxycorticosteroids in depressed patients. Psychosom. Med. 27: 299–308, 1965.

Bunney W. E. Jr. , Mason J. W. , Roatch J. F. , and Hamburg D. A. : A psychoendocrine study of severe psychotic depressive crises. Amer. J. Psychiat. 122: 72–80, 1965.

Bunney W. E. Jr. , Hartmann E. L. , and Mason J. W. : Study of a patient with 48 hour manic depressive cycles. Arch. Gen. Psychiat. 12: 619–625, 1965.

Bunney W. E. Jr. , and Davis J. M. : Norepinephrine in depressive reactions: A review. Arch. Gen. Psychiat. 13: 483–494, 1965.

Cannon W. B. : Bodily Changes in Pain, Hunger, Fear and Rage. New York, Appleton, 1915.

Cleghorn R. A. , and Austen D. C. : Effect of autonomic nerve stimulation and pressor drugs on the cardiovascular system of adrenalectomized dogs. (Can. Physiol. Soc. Proc.) Canad. Med. Assn. J. 39: 189, 1938.

Cleghorn R. A. , Fowler J. L. A. , Greenwood W. F. , and Clarke A. P. W. : Pressor responses in healthy adrenalectomized dogs. Amer. J. Physiol. 161(1): 21–28, 1950.

Cleghorn R. A. : Alerations in psychological states by therapeutic increase in adrenal cortical hormones. CIBA Found. Colloquia. Endocrinol. 3: 187–196, 1952.

Cochran B. Jr. , and Marbach E. P. : Some acute and chronic biochemical responses to electroconvulsive therapy. Recent Advances Biol. Psychiat. 4: 154–169, 1962.

Cumming J. , and Kort K. : Apparent reversal by cortisone of an electroconvulsive refractor state in a psychotic patient with Addison's disease. Canad. Med. Ass. J. 74: 291, 1956.

Curtis G. C. , Cleghorn R. A. , and Sourkes T. L. : The relationship between affect and the excretion of adrenaline, noradrenaline and 17-hydroxycorticosteroids. J. Psychosom. Research 4: 176–184, 1960.

Eik-Nes K. B. , and Brizzee K. R. : Concentration of tritium in brain tissue of dogs given (1,2 ³H₂) cortisol intravenously. Biochem. Biophys. Acta. 97: 320–333, 1965.

Elliott T. R. : On the action of Adrenaline. J. Physiol. 31: 20P, 1904.

Engel G. L. , and Margolin S. G. : Neuropsychiatric disturbances in Addison's disease and the role of impaired carbohydrate metabolism in production of abnormal cerebral function. Arch. Neurol. Psychiat. 45: 881–884, 1941.

Fawcett J. A. , and Bunney W. E. Jr. : Pituitary adrenal function and depression. Arch. Gen. Psychiat. 16: 517–535, 1967.

Freud S. : Three Essays on the Theory of Sexuality. London, Standard Edition, v. VII, Hogarth Press, 1905.

Gibbons J. L. , Gibson J. G. , Maxwell A. E. , and Willcox D. R. C. : An endocrine study of depressive illnesses. J. Psychosom. Res. 5: 32–41, 1960.

Gibbons J. L. , and McHugh P. R. : Plasma cortisol in depressive illness. J. Psychiat. Res. 1: 162–171, 1962.

Gibbons J. L. : Cortisol secretion rate in depressive illness. Arch. Gen. Psychiat. 10: 572–575, 1964.

Halberg F. : Eosinopenic effects of tryptamines in mice. Amer. J. Physiol. 179: 309, 1954.

Hamilton M. : A rating scale for depression. J. Neurol. Neurosurg. Psychiat. 23: 56–62, 1960.

Hartmann F. A. : The adrenal problem. Endocrinology 19: 633–638, 1935.

Hench P. S. , Kendall E. C. , Slocumb C. H. , and Polley H. F. : The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone: compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Prelim. Report. Proc. Mayo Clinic 24: 181–197, 1949.

Holmberg G. : Biological aspects of electroconvulsive therapy. Intern. Rev. Neurobiol. 5: 389–412, 1963.

Jakobson T. , Steinback A. , Strandstrom L. , and Rimon R. : The excretion of urinary 11-deoxy- and 11-oxy- 17-hydroxycorticosteroids in depressed patients during basal conditions and during the administration of methopyrapone. J. Psychosom. Res. 9: 363–374, 1966.

Kety S. S. : Catecholamines in neuropsychiatric states. Pharmacol. Rev. 18: 787, 1966.

Klerman G. L. , Schildkraut J. J. , Hasenbush L. L. , Greenblatt M. , Friend D. G. : Clinical experience with dihydroxyphenylalanine (DOPA) in depression. J. Psychiat. Res. 1: 289–297, 1963.

Kopin I. J. , and Gordon E. K. : Metabolism of norepinephrine-H³ released by tyramine and reserpine. J. Pharmacol. Exp. Ther. 138: 351–359, 1962.

Kopin I. J. , and Gordon E. K. : Metabolism of administered and drug released norepinephrine-7-H³ in the rat. J. Pharmacol. Exp. Ther. 140: 207–216, 1963.

Kurland G. S. , and Freedberg A. S. : The potentiating effect of ACTH and of cortisone pressor response to intravenous infusion of L-norepinephrine. Proc. Soc. Exp. Biol. Med. 78: 29–31, 1951.

Kurland H. D. : Steroid excretion in depressive disorders. Arch. Gen. Psychiat 10: 554, 1964/A.

Kurland H. D. : Urinary steroids in neurotic and manic depression. Proc. Soc. Exp. Biol. Med. 115: 723–725, 1964/B.

Kurland H. D. : Physiologic treatment of depressive reaction: A pilot study. Amer. J. Psychiat. 122: 457–458, 1965.

Lockett M. F. : Lower requirement of gland extract for maintenance in sympathectomized-adrenalectomized than in adrenalectomized bitches. J. Physiol. 110–19P, 1949.

Mayer-Gross W. , Slater E. , and Roth M. : Clinical Psychiatry. London, Cassell and Co. Ltd., 1960.

Murphy B. E. P. : Some studies of the protein-binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein-binding radioassay. J. Clin. Endocrin. Metab. 27 (7): 973–990, 1967.

Murphy H. B. M. , Wittkower E. D. , and Chance N. A. : Crosscultural inquiry into the symptomatology of depression. Transcultural Psychiat. Res. 1: 5–18, 1964.

McClure D. J. : The diurnal variation of plasma cortisol levels in depression. J. Psychosom. Res. 10: 189–195, 1966/A.

McClure D. J. : The effects of antidepressant medication on the diurnal plasma cortisol levels in depressed patients. J. Psychosom. Res. 10: 197–202, 1966/B.

Nichols T. , Nugent C. A. , and Tyler F. H. : Diurnal variation in suppression of adrenal function by glucocorticoids. J. Clin. Endocrin. Metab. 25: 343–349, 1965.

Persky H. : Adrenocortical function in anxious human subjects: The disappearance of hydrocortisone from plasma and its metabolic fate. J. Clin. Endoc. 17: 760–765, 1957.

Persky H. : Introduction and removal of hydrocortisone from plasma. Arch. Gen. Psychiat. 7: 93–97, 1962.

Peterson N. A. , and Chaikoff I. L. : Uptake of intravenously injected (4–¹⁴C) Cortisol by adult rat brain. J. Neurochem. 10: 17–23, 1963.

Pincus G. : Diurnal rhythm in the excretion of urinary ketosteroids by young men. J. Clin. Endocrin. Metab. 3: 195, 1943.

Platter F. : Praexos Medicae quoted in Classic Descriptions of Disease. Ed. Major R. H. . Springfield, Ill. C. C. Thomas, 1939, p. 280.

Porter R. W. : The central nervous system and stress-induced eosinopenia. Recent Prog. Hormone Res. 10: 1–27, 1954.

Prange A. J. Jr. , McCurdy R. L. , and Cochrane C. M. : The systolic blood pressure response of depressed patients to infused norepinephrine. J. Psychiat. Res. 5: 1–13, 1967.

Ramey E. R. , and Goldstein M. S. : The adrenal cortex and the sympathetic nervous system. Physiol. Rev. 37: 155–195, 1957.

Remington J. W. , Collings W. D. , Hays H. W. , Parkins W. M. , and Swingle W. W. : The response of the adrenalectomized dog to renin and other pressor agents. Amer. J. Physiol. 132: 622–628, 1941.

Rizzo M. D. , Fox H. M. , Laidlaw J. C. , and Thorn G. W. : Concurrent observations of behaviour changes and of adrenocortical variations in a cyclothymic patient during a period of twelve months. Ann. Intern. Med. 41: 798–815, 1954.

Rome H. P. , and Braceland F. J. : Psychological response to ACTH, cortisone, hydrocortisone, and related steroid substances. Amer. J. Psychiat. 108: 641–650, 1952.

Rosenblatt S. , Chanley J. D. , Sobotka H. , and Kaufman M. R. : Interrelationships between electroshock, the blood brain barrier and catecholamines. J. Neurochem. 5: 172–176, 1960.

Sachar E. J. : Corticosteroids in depressive illness. I. A revaluation of control issues and the Literature. Arch. Gen. Psychiat. 17: 544–553, 1967/A.

Sachar E. J. : Corticosteroids in depressive illness. II. A longitudinal psychoendocrine study. Arch. Gen. Psychiat. 17: 554–567, 1967/B.

Schildkrault J. J. , Klerman G. L. , Hammond R. , and Friend D. G. : Excretion of 3-methoxy-4-hydroxymandelic acid (VMA) in depressed patients treated with antidepressant drugs. J. Psychiat. Res. 2: 257–266, 1964.

Schildkraut J. J. : The catecholamine hypothesis of affective disorders: A review of supporting evidence. Amer. J. Psychiat. 122: 509–522, 1965.

Schildkraut J. J. , Gordon E. K. , and Durell J. : Catecholamine metabolism in affective disorders: I. Normetanephrine and VMA excretion in depressed patients treated with imipramine. J. Psychiat. Res. 3: 213–228, 1965.

Schildkraut J. J. , Green R. , Gordon E. K. , and Durell J. : Normetanephrine excretion and affective state in depressed patients treated with imipramine. Amer. J. Psychiat. 123: 690–700, 1966.

Schildkraut J. J. , and Kety S. S. : Biogenic amines and emotions. Science 156: 21–30, 1967.

Schwartz M. , Mandell A. J. , Green R. , and Ferman R. : Mood, motility and 17-hydroxycorticosteroid excretion: A polyvariable case study. Brit. J. Psychiat: 112: 149–156, 1966.

Sourkes T. L. : Editorial, Canad. Med. Ass. J. 96: 550–551, 1967.

Weil-Malherbe H. : The effect of convulsive therapy on plasma adrenaline and noradrenaline. J. Ment. Sci. 101: 156–162, 1955.

Wurtman R. J. , and Axelrod J. : Adrenal synthesis: Control by the pituitary gland and adrenal glucocorticoids. Science 150: 1464–1465, 1965.